Mixed‐effects models for slope‐based endpoints in clinical trials of chronic kidney disease

Mixed‐effects models for slope‐based endpoints in clinical trials of chronic kidney disease

In March of 2018, the National Kidney Foundation, in collaboration with the US Food and Drug Administration and the European Medicines Agency, sponsored a workshop in which surrogate endpoints other than currently established event‐time endpoints for clinical trials in chronic kidney disease (CKD) w...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Vonesh, E, Tighiouart, H, Ying, J, Heerspink, HL, Lewis, J, Staplin, N, Inker, L, Greene, T
Format:	Journal article
Sprog:	English
Udgivet:	Wiley 2019

Lignende værker

Comparing Bayesian hierarchical meta-regression methods and evaluating the influence of priors for evaluations of surrogate endpoints on heterogeneous collections of clinical trials
af: Willem Collier, et al.
Udgivet: (2024-02-01)

A meta-analysis of GFR slope as a surrogate endpoint for kidney failure
af: Inker, LA, et al.
Udgivet: (2023)

Acute treatment effects on GFR in randomized clinical trials of kidney disease progression
af: Neuen, B, et al.
Udgivet: (2021)

Allograft function as endpoint for clinical trials in kidney transplantation
af: Hilbrands, L, et al.
Udgivet: (2022)

Patient-reported outcomes as endpoints in clinical trials of kidney transplantation interventions
af: Tong, A, et al.
Udgivet: (2022)

Exploring Novel Endpoints for Clinical Trials in Kidney Disease: Challenges and Opportunities
af: Prabir Roy-Chaudhury
Udgivet: (2017-05-01)

Drug clinical trial landscape of chronic myeloid leukemia: achieving the endpoint or continuing the journey?
af: Shiyu Yang, et al.
Udgivet: (2024-11-01)

Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series
af: Michael S. Yule, et al.
Udgivet: (2024-06-01)

Establishing surrogate kidney endpoints for lupus nephritis clinical trials: development and validation of a novel approach to predict future kidney outcomes
af: Mackay, M, et al.
Udgivet: (2019)

Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series
af: Marianne J. Hjermstad, et al.
Udgivet: (2024-06-01)

Renal end points in clinical trials of kidney disease
af: Weldegiorgis, M, et al.
Udgivet: (2015)

Proposed definitions of antibody-mediated rejection for use as a clinical trial endpoint in kidney transplantation
af: Roufosse, C, et al.
Udgivet: (2022)

Proposed definitions of T cell-mediated rejection and tubulointerstitial inflammation as clinical trial endpoints in kidney transplantation
af: Seron, D, et al.
Udgivet: (2022)

Understanding the Use of Composite Endpoints in Clinical Trials
af: C. Eric McCoy
Udgivet: (2018-06-01)

2017 cardiovascular and stroke endpoint definitions for clinical trials
af: Hicks, KA, et al.
Udgivet: (2018)

2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials
af: Hicks, KA, et al.
Udgivet: (2018)

Discrepancies in endpoints between clinical trial protocols and clinical trial registration in randomized trials in oncology
af: Victoria J. Serpas, et al.
Udgivet: (2018-12-01)

Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series
af: James McDonald, et al.
Udgivet: (2023-10-01)

Rock endpoints and barriers estimation of slope failure in Pinousuk Gravel slopes using Rocfall simulation
af: H F W S Erfen, et al.
Udgivet: (2022)

Increasing the use of mobile technology-derived endpoints in clinical trials.
af: Herrington, W, et al.
Udgivet: (2018)

Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints series
af: Ola Magne Vagnildhaug, et al.
Udgivet: (2024-04-01)

Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints series
af: Leo R. Brown, et al.
Udgivet: (2024-06-01)

A potential primary endpoint for clinical trials in glaucoma neuroprotection
af: Carlos Gustavo De Moraes, et al.
Udgivet: (2023-05-01)

Evaluating glomerular filtration rate slope as a surrogate endpoint for ESKD in clinical trials: an individual participant meta-analysis of observational data
af: Grams, M, et al.
Udgivet: (2019)

Design and analysis of clinical trials with time-to-event endpoints /
af: Peace, Karl E., 1941-
Udgivet: (c200)

Evaluation of the True Endpoint of Clinical Trials for Cancer Cachexia
af: Tateaki Naito
Udgivet: (2019-01-01)

Significance of biomarkers and surrogate endpoints in preclinical and clinical trials
af: Ilić Katarina, et al.
Udgivet: (2007-01-01)

Patients’ preferences for selection of endpoints in cardiovascular clinical trials
af: Robert D. Chow, et al.
Udgivet: (2014-02-01)

Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial
af: Klaus F. Rabe, et al.
Udgivet: (2020-07-01)

Progress and opportunities in measuring the burden of Chronic Kidney Disease
af: Priya Vart, et al.
Udgivet: (2022-09-01)

Multimarker Panels in Diabetic Kidney Disease: The Way to Improved Clinical Trial Design and Clinical Practice?
af: Paul Perco, et al.
Udgivet: (2019-02-01)

Development of standard clinical endpoints for use in dengue interventional trials
af: Tomashek, Kay M., et al.
Udgivet: (2018)

Development of standard clinical endpoints for use in dengue interventional trials.
af: Kay M Tomashek, et al.
Udgivet: (2018-10-01)

Defining surrogate endpoints for clinical trials in severe Falciparum malaria.
af: Jeeyapant, A, et al.
Udgivet: (2017)

Development of standard clinical endpoints for use in dengue interventional trials
af: Tomashek, K, et al.
Udgivet: (2018)

Qualifying a Novel Clinical Trial Endpoint (iBOX) Predictive of Long-Term Kidney Transplant Outcomes
af: Amanda Klein, et al.
Udgivet: (2023-09-01)

Clinical Trial Risk in Hepatitis C: Endpoint Selection and Drug Action
af: Nicole A. Tillie, et al.
Udgivet: (2016-01-01)

Informative noncompliance in endpoint trials
af: Iglewicz Boris, et al.
Udgivet: (2004-07-01)

The importance of appropriate selection of clinical endpoints in outpatient COVID-19 clinical trials
af: Thorlund, K, et al.
Udgivet: (2023)

When do we need clinical endpoint adjudication in clinical trials?
af: Claes Held
Udgivet: (2019-01-01)